Envista outlines 2026 adjusted EPS of $1.54 to $1.58 while anticipating China VBP implementation in H1 2027 (NYSE:NVST)
Envista Holdings (NVST) reported Q3 2026 core sales growth of 2.7%, adjusted EBITDA growth of 9%, and adjusted EPS growth of 25%. The company expects 2026 adjusted EPS of $1.54 to $1.58 and anticipates China VBP implementation in H1 2027.
How this was made
The 30-second read
Why it matters
The guidance will influence analyst forecasts and may move the stock as investors reassess growth expectations.
Market read
Guidance release is the primary catalyst for NVST's near‑term price action.
What to watch
Potential impact of China VBP implementation in 2027 could affect future earnings.
Background
Envista Holdings Corp. (NVST) provided Q3 2026 performance metrics and forward EPS guidance during its earnings call.
Ticker impact
Envista disclosed its 2026 adjusted EPS guidance of $1.54‑$1.58 in the earnings call.
potential modest upside if guidance exceeds market expectations; downside risk if seen as weak.
The new EPS range is the first disclosed guidance; traders will price in the outlook.
Market effects
Sets a benchmark for dental equipment and services peers.
Limited to U.S. and global dental market participants.
Low; primarily affects Envista and its direct competitors.
Counterpoint
Guidance may be overly optimistic given recent sales growth slowdown.
Key entities
- companyEnvista Holdings Corp.
Dental equipment and services provider.
- executivePaul Keel
President, CEO & Chairman of Envista.
